X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (181) 181
Publication (6) 6
Book / eBook (4) 4
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
female (41) 41
male (40) 40
animals (26) 26
adult (22) 22
middle aged (22) 22
aged (21) 21
oncology (20) 20
index medicus (18) 18
cancer (11) 11
chemotherapy (10) 10
biochemistry & molecular biology (9) 9
carcinoma (9) 9
pharmacology & pharmacy (9) 9
mice (8) 8
rats (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
japan (7) 7
lung neoplasms - drug therapy (7) 7
medicine & public health (7) 7
neoplasm staging (7) 7
research (7) 7
survival analysis (7) 7
adolescent (6) 6
analysis (6) 6
carcinoma, non-small-cell lung - drug therapy (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
cisplatin (5) 5
cisplatin - administration & dosage (5) 5
gene (5) 5
japan - epidemiology (5) 5
molecular sequence data (5) 5
mortality (5) 5
survival rate (5) 5
therapy (5) 5
trial (5) 5
adenocarcinoma (4) 4
age factors (4) 4
amino acid sequence (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
association (4) 4
chemistry (4) 4
chemistry, multidisciplinary (4) 4
chemistry, organic (4) 4
drug administration schedule (4) 4
lung neoplasms - pathology (4) 4
medicine, general & internal (4) 4
medicine, research & experimental (4) 4
molecular structure (4) 4
public, environmental & occupational health (4) 4
rat (4) 4
risk factors (4) 4
surgery (4) 4
toxicity (4) 4
adenocarcinoma - pathology (3) 3
age (3) 3
article (3) 3
cancer research (3) 3
carboplatin (3) 3
cell biology (3) 3
cells, cultured (3) 3
child (3) 3
child, preschool (3) 3
clinical neurology (3) 3
cohort studies (3) 3
cohort study (3) 3
diagnosis (3) 3
emesis (3) 3
etoposide (3) 3
expression (3) 3
follow-up (3) 3
follow-up studies (3) 3
gastroenterology & hepatology (3) 3
gemcitabine (3) 3
hematology (3) 3
hepatocellular carcinoma (3) 3
incidence (3) 3
injections, intraperitoneal (3) 3
kinetics (3) 3
liver (3) 3
logistic models (3) 3
men (3) 3
microbiology (3) 3
motion sickness (3) 3
multidisciplinary sciences (3) 3
patients (3) 3
performance (3) 3
physical sciences (3) 3
physics (3) 3
polymerase chain reaction (3) 3
pregnancy (3) 3
prognosis (3) 3
prospective studies (3) 3
recurrence (3) 3
retrospective studies (3) 3
spectrophotometry (3) 3
structure-activity relationship (3) 3
time factors (3) 3
young adult (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1994, Artech House telecommunications library., ISBN 0890066221, x, 174
Book
2005, Shohan., Sōsho "rinrigaku no furontia", ISBN 4888489491, Volume 12, xv, 295
Book
by Aharonian, F and Akamatsu, H and Akimoto, F and Allen, SW and Angelini, L and Audard, M and Awaki, H and Axelsson, M and Bamba, A and Bautz, MW and Blandford, R and Brenneman, LW and Brown, GV and Bulbul, E and Cackett, EM and Chernyakova, M and Chiao, MP and Coppi, PS and Costantini, E and de Plaa, J and de Vries, CP and den Herder, JW and Done, C and Dotani, T and Ebisawa, K and Eckart, ME and Enoto, T and Ezoe, Y and Fabian, AC and Ferrigno, C and Foster, AR and Fujimoto, R and Fukazawa, Y and Furuzawa, A and Galeazzi, M and Gallo, LC and Gandhi, P and Giustini, M and Goldwurm, A and Gu, LY and Guainazzi, M and Haba, Y and Hagino, K and Hamaguchi, K and Harrus, IM and Hatsukade, I and Hayashi, K and Hayashi, T and Hayashida, K and Hiraga, JS and Hornschemeier, A and Hoshino, A and Hughes, JP and Ichinohe, Y and Iizuka, R and Inoue, H and Inoue, Y and Ishida, M and Ishikawa, K and Ishisaki, Y and Iwai, M and Kaastra, J and Kallman, T and Kamae, T and Kataoka, J and Katsuda, S and Kawai, N and Kelley, RL and Kilbourne, CA and Kitaguchi, T and Kitamoto, S and Kitayama, T and Kohmura, T and Kokubun, M and Koyama, K and Koyama, S and Kretschmar, P and Krimm, HA and Kubota, A and Kunieda, H and Laurent, P and Lee, SH and Leutenegger, MA and Limousin, O and Loewenstein, M and Long, KS and Lumb, D and Madejski, G and Maeda, Y and Maier, D and Makishima, K and Markevitch, M and Matsumoto, H and Matsushita, K and McCammon, D and McNamara, BR and Mehdipour, M and Miller, ED and Miller, JM and Mineshige, S and ... and Hitomi Collaboration and SLAC National Accelerator Lab., Menlo Park, CA (United States) and Fysikum and Naturvetenskapliga fakulteten and Stockholms universitet and Oskar Klein-centrum för kosmopartikelfysik (OKC)
PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN, ISSN 0004-6264, 12/2018, Volume 70, Issue 6
We present the results from the Hitomi Soft Gamma-ray Detector (SGD) observation of the Crab nebula. The main part of SGD is a Compton camera, which in... 
PULSAR | polarization | instrumentation: polarimeters | SEMICONDUCTOR COMPTON CAMERA | X-rays: individual (Crab) | ASTRONOMY & ASTROPHYSICS | Physics - High Energy Astrophysical Phenomena | X-rays: individual | ASTRONOMY AND ASTROPHYSICS | OTHER INSTRUMENTATION | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2013, Volume 110, Issue 3, pp. 954 - 959
Journal Article
Journal Article
Nagoya Journal of Medical Science, ISSN 0027-7622, 2014, Volume 76, Issue 3-4, pp. 235 - 254
Journal Article
Materials Transactions, ISSN 1345-9678, 2013, Volume 54, Issue 9, pp. 1818 - 1822
Journal Article
Journal of Power Sources, ISSN 0378-7753, 05/2011, Volume 196, Issue 10, pp. 4555 - 4563
▶ 3D microstructure of SOFC porous anode is directly observed by FIB–SEM. ▶ Microstructural parameters characterizing the porous structure are quantified. ▶... 
Numerical simulation | FIB–SEM | Microstructure | Random walk | SOFC | FIB-SEM | TOMOGRAPHY | ELECTROCHEMISTRY | ENERGY & FUELS | RECONSTRUCTION | PERFORMANCE | SOFC ANODE | MODEL | DIFFUSION | Scanning electron microscopy | Solid oxide fuel cells | Computer simulation | Mathematical models | Boundaries | Density | Anodes | Ion beams
Journal Article
Journal Article
Pediatrics International, ISSN 1328-8067, 10/2017, Volume 59, Issue 10, pp. 1046 - 1052
Background The combination of fludarabine (Flu), high‐dose cytarabine (Ara‐C) and granulocyte colony‐stimulating factor (G‐CSF; FLAG), with anthracyclines has... 
FLAG‐IDA | minimal residual disease | acute myeloid leukemia | children | relapse | FLAG-IDA | CYTOSINE-ARABINOSIDE | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | RANDOMIZED-TRIAL | HIGH-DOSE CYTARABINE | G-CSF | LIPOSOMAL DAUNORUBICIN | PHASE-II TRIAL | INITIAL THERAPY | PEDIATRICS | Recombinant Proteins - therapeutic use | Recurrence | Drug Administration Schedule | Cytarabine - therapeutic use | Humans | Child, Preschool | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Vidarabine - analogs & derivatives | Vidarabine - therapeutic use | Granulocyte Colony-Stimulating Factor - therapeutic use | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Leukemia, Myeloid, Acute - drug therapy | Female | Child | Idarubicin - therapeutic use | Relapse | Chemotherapy | Anthracyclines | Granulocyte colony-stimulating factor | Influenza | Meningitis | Transplantation | Hematopoietic stem cells | Diseases | Cancer | Flow cytometry | Toxicity | Leukemia | Stem cell transplantation | Cerebrospinal fluid | Cytarabine | Granulocytes | Bone marrow | Remission | Bacteria | Colony-stimulating factor | Children | Hematology | Colonies | Myeloid leukemia | Medical treatment | Minimal residual disease | Wilms' tumor | Patients | Lymphoma | Hemopoiesis | Cytometry | Fludarabine | Anthracycline | Fatalities | Adults | Leukocytes (granulocytic) | Acute myeloid leukemia
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0147570
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2014, Volume 74, Issue 4, pp. 721 - 727
The population of elderly patients with lung cancer is increasing worldwide. Although first-line gefitinib is one of the standard treatments for advanced... 
EGFR mutation | First-line treatment | Medicine & Public Health | Non-small cell lung cancer | Oncology | Cancer Research | Pharmacology/Toxicology | Gefitinib | Elderly | Quality of life | SURVIVAL | MONOTHERAPY | ADENOCARCINOMA | PHASE-III | CHEMOTHERAPY | PACLITAXEL | TRIAL | ONCOLOGY | CLINICALLY SELECTED PATIENTS | CARBOPLATIN/PACLITAXEL | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | Japan - epidemiology | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Age Factors | Humans | Lung Neoplasms - pathology | Male | Antineoplastic Agents - administration & dosage | Drug Monitoring - methods | Lung Neoplasms - physiopathology | Carcinoma, Non-Small-Cell Lung - physiopathology | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Aged, 80 and over | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Liver Function Tests | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - epidemiology | Disease Progression | Disease-Free Survival | Lung Neoplasms - epidemiology | Quinazolines - adverse effects | Quality of Life | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Drug Screening Assays, Antitumor | Care and treatment | Oncology, Experimental | Aged patients | Development and progression | Lung cancer, Small cell | Genetic aspects | Research | Lung cancer, Non-small cell | Health aspects | Cancer
Journal Article
Journal Article